Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.
about
Cognitive and emotional alterations are related to hippocampal inflammation in a mouse model of metabolic syndrome.Clinical Effects of Rhus coriaria Fruits on Dyslipidemia308 in Adolescents: a Triple-blinded Randomized Placebo-controlled Trial.Association of waist and hip circumferences with the presence of hypertension and pre-hypertension in young South African adults.Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice.The effect of abdominal fat parameters on percutaneous nephrolithotomy success.Population shifts and the future of stroke: forecasts of the future burden of stroke.Effect of Hibiscus sabdariffa Calices on Dyslipidemia in Obese Adolescents: A Triple-masked Randomized Controlled Trial.Dyslipidemia incidence and the trend of lipid parameters changes in women with history of gestational diabetes: a 15-year follow-up study.Safety assessment of an anti-obesity drug (sibutramine): a retrospective cohort study.Plasma glutaredoxin activity in healthy subjects and patients with abnormal glucose levels or overt type 2 diabetes.Blood Pressure Control in Canada: Through the Looking-Glass Into a Glass Half Empty?An inhibitor of 11-β hydroxysteroid dehydrogenase type 1 (PF915275) alleviates nonylphenol-induced hyperadrenalism and adiposity in rat and human cells.Bioeconomy: The Path to SustainabilityIntensification of Basal Insulin Therapy with Lixisenatide in Patients with Type 2 Diabetes in a Real-World Setting: The BASAL-LIXI Study
P2860
Q34031315-A672935F-7D32-4B7F-B00C-56B3441639FCQ34725383-8C538672-B199-456B-9D47-3F0D961C8CA6Q36612691-734E30CB-BF6C-4344-A829-2AC938E7EFBCQ36941874-36CBA8B1-A722-4CC6-B18D-C076FAB2DEC6Q37004006-23C66D9D-BD29-4882-8F17-A28FA544FEBDQ37056501-5094C7F9-ACF7-4B6D-8598-33D366F4940AQ37160353-A5529854-1197-40B1-8B4D-72F4DEE37D3EQ40051706-B80B2ABE-09A9-4551-BD0E-EC59A07BB589Q47392852-40F2B569-ECDF-486B-BBC2-EBB7ABDCA528Q50850806-E7F7FD03-A08A-4C67-842B-0B0F9D3667E7Q53968418-A044FB22-7114-4480-B24F-B179FD1B4573Q55715253-B2C823D9-264B-41FE-AD9C-ED1F3FC61A5BQ58176404-06ACEF1B-8B72-460F-9044-DCB7112704CDQ59137107-9052D0AD-3CE0-414B-861C-2335147815FF
P2860
Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.
description
2010 nî lūn-bûn
@nan
2010 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.
@ast
Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.
@en
type
label
Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.
@ast
Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.
@en
prefLabel
Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.
@ast
Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome.
@en
P2860
P921
P1476
Prevention of cardiovascular disease: obesity, diabetes and the metabolic syndrome
@en
P2093
Arya M Sharma
P2860
P304
P356
10.1016/S0828-282X(10)71077-1
P478
26 Suppl C
P50
P577
2010-08-01T00:00:00Z